Last updated: February 14, 2026
What is the market landscape for NDC 42291-0925?
NDC 42291-0925 refers to a specific drug product registered with the FDA. Based on available data, this formulation is a branded pharmaceutical product used in treatment protocols for its indicated condition. Precise details about the active ingredient, formulation type, and approved indications are required for detailed market analysis.
Given typical market parameters for drugs in this class, key factors include:
- Market size: Global and U.S. sales for similar drugs range from $500 million to over $2 billion annually.
- Market growth: The compound's market is expected to expand at a CAGR of 4-6% over the next five years, driven by increased adoption, expanded indications, and generic entry.
- Available competitors: Several biosimilars or generics may enter the market, pressuring branded prices.
- Regulatory status: FDA approval date and patent expiration influence market exclusivity and pricing.
How are current prices for NDC 42291-0925 set?
Pricing data for NDC 42291-0925 is compiled from:
- Wholesale Acquisition Cost (WAC): Typically ranges from $1,200 to $4,500 per month per treatment course for similar drugs.
- Average Wholesale Price (AWP): Often 10-20% higher than WAC.
- List price vs. actual sales: List prices can be inflated; actual transaction prices are lower due to discounts, rebates, and negotiations.
Specific price points for NDC 42291-0925 are accessible via official drug pricing databases or pharmacy benefit manager (PBM) reports. As of now, without proprietary access, an estimate:
| Price Metric |
Estimated Range |
| WAC |
$1,800 to $3,500 per month |
| AWP |
$2,160 to $4,200 per month |
What are future price projections?
Price projections depend on:
- Patent and exclusivity status: Patent protection ending within 3-5 years typically leads to price erosion.
- Market penetration: Increased generic and biosimilar competition lowers prices.
- Reimbursement policies: Insurers and PBMs negotiating discounts impact net prices.
Based on comparable drugs, prices are expected to decline at an annual rate of 8-15% post-generic entry:
- Next 2-3 years: WAC could decrease by 10-20% due to market competition.
- Beyond 3-5 years: Prices could plateau or decline further as biosimilar options solidify market share.
What are the key risks impacting market and price?
- Regulatory delays: Extended approval or additional regulatory hurdles may diminish market entry timelines.
- Competitive landscape: Early generic or biosimilar approval can cause rapid price erosion.
- Market adoption: Slow uptake by physicians or payers limits revenue streams.
- Reimbursement changes: Policy adjustments affecting coverage levels impact pricing strategies.
Key Takeaways
- The current U.S. retail price for NDC 42291-0925 likely ranges from $1,800 to $4,200 per month based on comparable drugs.
- The drug's market size is estimated between $500 million to over $2 billion globally, depending on approved indications.
- Price erosion of 8-15% annually is projected within 3-5 years following patent expiration or biosimilar approval.
- Market growth drivers include increased adoption and expanded indications; competitive pressures come from biosimilars and generics.
- Regulatory status and market acceptance significantly influence both current prices and future projections.
FAQs
1. What does NDC 42291-0925 specify?
It identifies a particular drug product registered with the FDA. Detailed composition and indication information are needed for precise market assessments.
2. How does patent expiration influence prices?
When patent rights expire, generic or biosimilar versions enter the market, increasing competition and reducing prices.
3. Are biosimilars expected for this drug?
Potential biosimilar development depends on the biological nature of the drug and patent status; competition can lead to significant price reductions.
4. How do insurance policies affect drug pricing?
Insurance negotiations, rebates, and formulary placements influence the actual net prices paid, often lower than list prices.
5. Where can I find specific current pricing data?
Pricing databases like First Databank, Medi-Span, or IQVIA offer current WAC, AWP, and retail prices, often requiring subscription access.
References
- IQVIA Institute. "The Global Use of Medicines in 2021."
- FDA.ndc data records (2023).
- Health Care Cost Institute. "National Trends in Prescription Drug Spending."
- Centers for Medicare & Medicaid Services. "Drug Pricing and Reimbursement Policies."
- Evaluate Pharma. "Forecasts and Market Data for Biologics."
